BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15995238)

  • 1. Protection of dogs for 13 months against Bordetella bronchiseptica and canine parainfluenza virus with a modified live vaccine.
    Jacobs AA; Theelen RP; Jaspers R; Horspool LJ; Sutton D; Bergman JG; Paul G
    Vet Rec; 2005 Jul; 157(1):19-23. PubMed ID: 15995238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
    Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs.
    Ellis JA; Haines DM; West KH; Burr JH; Dayton A; Townsend HG; Kanara EW; Konoby C; Crichlow A; Martin K; Headrick G
    J Am Vet Med Assoc; 2001 Feb; 218(3):367-75. PubMed ID: 11201562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine parainfluenza-Bordetella bronchiseptica vaccine immunogenicity.
    Chladek DW; Williams JM; Gerber DL; Harris LL; Murdock FM
    Am J Vet Res; 1981 Feb; 42(2):266-70. PubMed ID: 6266289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs.
    Lehar C; Jayappa H; Erskine J; Brown A; Sweeney D; Wassmoen T
    Vet Ther; 2008; 9(4):257-62. PubMed ID: 19177330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous analysis of the nasal shedding kinetics of field and vaccine strains of Bordetella bronchiseptica.
    Iemura R; Tsukatani R; Micallef MJ; Taneno A
    Vet Rec; 2009 Dec; 165(25):747-51. PubMed ID: 20023279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus 2, Bordetella bronchiseptica, and Parainfluenza Molecular Diagnostic Assay Results in Puppies After vaccination with Modified Live Vaccines.
    Ruch-Gallie R; Moroff S; Lappin MR
    J Vet Intern Med; 2016; 30(1):164-6. PubMed ID: 26692461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of intranasal and oral vaccines against Bordetella bronchiseptica in dogs.
    Ellis JA; Gow SP; Waldner CL; Shields S; Wappel S; Bowers A; Lacoste S; Xu Z; Ball E
    Vet J; 2016 Jun; 212():71-7. PubMed ID: 27256028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiological survey of Bordetella bronchiseptica and canine parainfluenza-2 virus in dogs in Sweden.
    Englund L; Jacobs AA; Klingeborn B; ChriƩl M
    Vet Rec; 2003 Mar; 152(9):251-4. PubMed ID: 12638909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of puppies against canine herpesvirus by vaccination of the dams.
    Poulet H; Guigal PM; Soulier M; Leroy V; Fayet G; Minke J; Chappuis Merial G
    Vet Rec; 2001 Jun; 148(22):691-5. PubMed ID: 11425256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough).
    Kontor EJ; Wegrzyn RJ; Goodnow RA
    Am J Vet Res; 1981 Oct; 42(10):1694-8. PubMed ID: 6275747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intranasal administration of a modified live feline herpesvirus 1 and feline calicivirus vaccine against disease caused by Bordetella bronchiseptica after experimental challenge.
    Bradley A; Kinyon J; Frana T; Bolte D; Hyatt DR; Lappin MR
    J Vet Intern Med; 2012; 26(5):1121-5. PubMed ID: 22860699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the mucosal immune response in dogs vaccinated with either an intranasal avirulent live culture or a subcutaneous antigen extract vaccine of Bordetella bronchiseptica.
    Davis R; Jayappa H; Abdelmagid OY; Armstrong R; Sweeney D; Lehr C
    Vet Ther; 2007; 8(1):32-40. PubMed ID: 17447223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating Bordetella bronchiseptica-reactive antibody responses in seropositive dogs.
    Ellis JA; Krakowka GS; Dayton AD; Konoby C
    J Am Vet Med Assoc; 2002 Jan; 220(1):43-8. PubMed ID: 12680446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular necrosis associated with the subcutaneous injection of an intranasal Bordetella bronchiseptica-canine parainfluenza vaccine.
    Toshach K; Jackson MW; Dubielzig RR
    J Am Anim Hosp Assoc; 1997; 33(2):126-8. PubMed ID: 9111722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination against Bordetella bronchiseptica infection in dogs using a heat-killed bacterial vaccine.
    McCandlish IA; Thompson H; Wright NG
    Res Vet Sci; 1978 Jul; 25(1):45-50. PubMed ID: 705048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiology of respiratory (group 2) canine coronavirus, canine parainfluenza virus, and Bordetella bronchiseptica infections in urban dogs in a humane shelter and in rural dogs in small communities.
    Ellis J; Anseeuw E; Gow S; Bryan H; Salb A; Goji N; Rhodes C; La Coste S; Smits J; Kutz S
    Can Vet J; 2011 Aug; 52(8):861-8. PubMed ID: 22294792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the efficacy of a novel intranasal vaccine against feline bordetellosis.
    Williams J; Laris R; Gray AW; Jacobs AA
    Vet Rec; 2002 Apr; 150(14):439-42. PubMed ID: 11993973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feline bordetellosis: challenge and vaccine studies.
    Jacobs AA; Chalmers WS; Pasman J; van Vugt F; Cuenen LH
    Vet Rec; 1993 Sep; 133(11):260-3. PubMed ID: 8236648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against canine bordetellosis: protection from contact challenge.
    McCandlish IA; Thompson H; Wright NG
    Vet Rec; 1978 Jun; 102(22):479-83. PubMed ID: 685092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.